Co-Founder, Healthcare Technology Leader, Board Director

Afia Asamoah is a strategic technology leader and senior executive with over 15 years experience guiding companies at the convergence of technology and healthcare, during dynamic periods of innovation and transformation. In 2021, she co-founded Waymark to focus on improving care delivery to people with Medicaid benefits, combining her interests in focusing innovation to improve health care to underrepresented and lower income populations. She currently leads the legal, people, security and compliance functions.

Scholar, Research Fellow

Dr. Artem A. Trotsyuk is a postdoctoral fellow with the Stanford Center for Biomedical Ethics, a research fellow with the Stanford Center for Human-Centered Artificial Intelligence and The Hoover Institute. He completed his PhD in Bioengineering and Masters in Computer Science with an AI specialization at Stanford University under the supervision of Dr. Geoffrey Gurtner in the Department of Surgery. He was co-advised by Dr. Zhenan Bao in the Department of Chemical Engineering alongside Dr. Russ Altman and Dr. Michael Snyder. His thesis focused on developing a smart bandage that implements a closed-loop AI processing system for sensing and therapeutic delivery into a wound bed. Broadly, his research interests lie in bioengineering, gene editing, wearables, CRISPR therapy, regenerative medicine and ethical use of data in drug development.

Scientist, Oncologist, Author

Dr. Azra Raza is the Chan Soon-Shiong Professor of Medicine and Director of the MDS Center at Columbia University in New York. She is an accomplished scientist who supervises a state-of-the-art basic research lab and a Tissue Repository of blood and marrow samples collected since 1984. Dr. Raza is a dedicated reader of Urdu literature, the co-author of GHALIB: Epistemologies of Elegance. She is the author of The First Cell: And the Human Costs of Pursuing Cancer to the Last published by Basic Books, October 2019.

Educator, Researcher, Physician

Bryant Lin, MD, MEng is a primary care physician, educator and researcher. The cornerstone of Dr. Lin's work is keeping medicine focused on humans - patients, providers, families and trainees - and not lost in technology and algorithms. He is an accomplished inventor with 12 issued US patents and an experienced entrepreneur. Dr. Lin holds appointments as Clinical Professor of Medicine, Co-Director of the Center for Asian Health Research and Education (CARE) and Director of Medical Humanities and Arts at Stanford.

Researcher, Data Scientist

Christina Curtis, PhD, MSc is a Professor of Medicine, Genetics and Biomedical Data Science and an Endowed Scholar at Stanford University where she leads the Cancer Computational and Systems Biology group. Dr. Curtis also serves as the Director of Artificial Intelligence and Cancer Genomics, Director of Breast Cancer Translational Research and Co-Director of the Molecular Tumor Board at the Stanford Cancer Institute. Dr. Curtis’s laboratory leverages computational modeling, high-throughput molecular profiling and experimentation to develop new ways to prevent, diagnose and treat cancer.

Scientist, Epidemiologist

David Rehkopf is a social epidemiologist and serves as an Associate Professor in the Department of Epidemiology and Population Health and in the Department of Medicine in the Division of Primary Care and Population Health. He joined the faculty at Stanford School of Medicine in 2011. He is currently the co-director of the Stanford Center for Population Health Sciences. In this position he is committed to making high value data resources available to researchers across disciplines in order to better enable them to answer their most pressing clinical and population health questions.

Global Chief Medical Officer

Dr. David C. Rhew is the Global Chief Medical Officer (CMO) & VP of Healthcare for Microsoft. He is Adjunct Professor at Stanford University; holds six U.S. technology patents that enable authoring, mapping, and integration of clinical decision support into electronic health records; and has been recognized as one of the 50 most influential clinician executives by Modern Healthcare.

Dr. Rhew received his Bachelors of Science degrees in computer science and cellular molecular biology from University of Michigan. He received his MD degree from Northwestern University and completed internal medicine residency at Cedars-Sinai Medical Center. He completed fellowships in health services research at Cedars-Sinai and infectious diseases at the University of California, Los Angeles.

He has served as CMO and VP for Samsung; SVP and CMO at Zynx Health Incorporated; clinician/researcher at the VA Greater Los Angeles Healthcare System and RAND; and Associate Clinical Professor of Medicine at UCLA. Dr. Rhew has served on the National Quality Forum’s Executive Committee for Consensus Standards and Approval, Chaired the Consumer Technology Association Health Technology Board, and sits on the Governing Committee for NESTcc (National Evaluation System for health Technology coordinating center), the medical device advisory group for the FDA, CMS, and NIH.

Emeritus Chair of Urology, Researcher

Eric A. Klein, MD, is Distinguished Scientist at GRAIL, Emeritus Chairman of the Glickman Urological & Kidney Institute, Professor of Surgery at the Cleveland Clinic Lerner College of Medicine, and a member of the Department of Cancer Biology in the Lerner Research Institute. His clinical and research interests are in genitourinary cancers with special expertise in prostate cancer. He serves as editor-in-chief for UROLOGY, one of the four major urologic journals. He has published more that 700 peer-reviewed papers including discovery papers that served as the basis for clinical assays for prostate cancer including isoPSA (a blood based assay with improved diagnostic accuracy) and OncotypeDx Prostate, a gene expression assay that characterizes biologic aggressiveness.

Oncologist, Primary Care Physician, Author

Dr. Yurkiewicz is a practicing physician and medical journalist on the faculty at Stanford University School of Medicine. Board certified in internal medicine, oncology, and hematology, she is a Clinical Assistant Professor of Primary Care and Population Health in the Department of Medicine and Co-Director of Primary Care for Cancer Survivorship. Dr. Yurkiewicz is an award-winning physician-writer whose work has appeared in The Best American Science and Nature Writing, the Atlantic, Scientific American, and elsewhere. She is the author of the new book, Fragmented: A Doctor’s Quest to Piece Together American Health Care, from the publisher W.W. Norton.

Co-Founder, Chairperson Health Unity

Jia is passionate about the potential for artificial intelligence to improve our lives. She is elected as IEEE Fellow for Leadership in Large Scale AI. She is the Co-founder and Chairperson of HealthUnity. In the past, she served different roles including an Adjunct Professor at Stanford University. She was the Co-founder and Head of R&D at Google Cloud AI. At Google, she oversaw the development of the full stack of AI products on Google Cloud to power solutions for diverse industries with healthcare as one of the top verticals.

Physician-Scientist

Jonathan H Chen MD, PhD is a physician-scientist with professional software development experience and graduate training in computer science. He continues to practice Internal Medicine for the concrete rewards of caring for real people and to inspire his research focused on mining clinical data sources to inform medical decision making.

Digital Health Venture Capital Investor

Justin Norden is a Partner at GSR Ventures, where he focuses on early-stage investments in digital health. Prior to GSR Ventures, he was CEO and co-founder of Trustworthy AI which was acquired by Waymo (Google self-driving). He worked on the healthcare team at Apple, co-founded Indicator (an NLP based platform for biopharma decision making), and helped start the Stanford Center for Digital Health.

NYT Bestselling Author

New York Times bestselling author and Stanford professor LAUREL BRAITMAN is a driving force in bridging the gap between storytelling and the medical world. She works with doctors and medical students—who, like many other frontline workers, are facing record levels of burnout—and proves that the simple act of telling our own stories can help build community, improve mental health, and equip us with the communication skills we need to make a real difference for those around us.

Dean, Stanford University School of Medicine

Lloyd B. Minor, MD, is the Carl and Elizabeth Naumann Dean of the Stanford University School of Medicine. Under his leadership, Stanford Medicine has pioneered the Precision Health revolution, which emphasizes preventive, personalized health care and leverages advances in biomedicine to treat and cure complex diseases. His book, “Discovering Precision Health,” illustrates how Stanford Medicine and other health leaders are revolutionizing biomedicine. In 2021, Dr. Minor articulated and began realizing a bold vision to transform the future of life sciences at Stanford University and beyond – a multi-decade journey enabled by Precision Health. Dr. Minor also is a professor of Otolaryngology–Head and Neck Surgery and a professor of Bioengineering and of Neurobiology, by courtesy. With more than 160 published articles and chapters, Dr. Minor is an expert in balance and inner ear disorders. In 2012, he was elected to the National Academy of Medicine.

Geriatrician, Writer, Educator

Louise Aronson, MD MFA, is a leading geriatrician, writer, educator, and professor of medicine at the University of California, San Francisco. The author of the New York Times bestseller and Pulitzer Prize finalist Elderhood, she is a regular contributor to the New York Times and the New England Journal of Medicine among other publications. Recognition of Louise’s work includes a MacDowell fellowship, four Pushcart nominations, the American Geriatrics Society Clinician-Teacher of the Year award, and a Gold Professorship for Humanism in Medicine.tion goes here

Researcher, Chair of the Dept of Genetics

Michael Snyder is the Stanford Ascherman Professor and Chair of Genetics and the Director of the Center of Genomics and Personalized Medicine. He is a leader in the field of functional genomics and multiomics, and one of the major participants of the ENCODE project. His laboratory study was the first to perform a large-scale functional genomics project in any organism, and has developed many technologies in genomics and proteomics. Seminal findings from the Snyder laboratory include the discovery that much more of the human genome is transcribed and contains regulatory information than was previously appreciated (e.g. lncRNAs and TF binding sites), and a high diversity of transcription factor binding occurs both between and within species. He launched the field of personalized medicine by combining different state-of–the-art “omics” technologies to perform the first longitudinal detailed integrative personal omics profile (iPOP) of a person, and his laboratory pioneered the use of wearables technologies (smart watches and continuous glucose monitoring) for precision health. He is a cofounder of many biotechnology companies, including Personalis, SensOmics, Qbio, January, Protos, Oralome, Mirvie and Filtricine.

Chief Data Scientist

Dr. Nigam Shah is Professor of Medicine (Biomedical Informatics) at Stanford University, Chief Data Scientist at Stanford Healthcare, and a member of the Biomedical Informatics Graduate Program as well as the Clinical Informatics Fellowship. Dr. Shah's research focuses on combining machine learning and prior knowledge in medical ontologies to enable use cases of the learning health system.

Epidemiologist, Physician

Dr. Nisha Parikh is an Associate Professor of Medicine at UCSF, a noninvasive cardiologist and cardiovascular epidemiologist. She completed her MPH at UC Berkeley, Internal Medicine Residency at Tufts, Cardiology fellowship at Harvard Beth-Israel Deaconess, and Cardiovascular Epidemiology fellowship at Boston University. Her interests are in primary and secondary cardiovascular disease prevention including cardiovascular disease in pregnancy and the post-partum period. She has also studied the effects of methamphetamine use on cardiovascular health in men and women. She demonstrated in the Multi-Ethnic Study of Atherosclerosis that the hemodynamic changes of pregnancy may not revert back to normal, may be cumulative across successive pregnancies, and can lead to left ventricular remodeling on cardiac MRI in mid-life. Along with a research team at the Framingham Heart Study, she developed the first risk score for incident hypertension. Her work has been supported by grants from the American Heart Association and the NIH/National Heart Lung and Blood Institute. She is a member of the UCSF cardio-obstetrics program. She has been a volunteer at the American Heart Association for over a decade where she has served on several local and national boards and committees including leadership, membership, publications and heart and stroke statistics. She is a Deputy Editor at UpToDate, WoltersKluwer where she in responsible for over 200 topics in cardiology.

Writer, Teacher, Physician

Ricardo Nuila is a writer and an associate professor of medicine at Baylor College of Medicine. For the past thirteen years, he has worked as a hospitalist and attending at Houston's largest safety net facility, Ben Taub Hospital. Ricardo's essays and articles on health disparities have been featured in The New Yorker, The New York Times, Texas Monthly, The Atlantic, and The New England Journal of Medicine. Fictional works have appeared in The Best American Short Stories anthology, Guernica, and McSweeney's. He is the director of the Humanities Expression and Arts Lab (HEAL) at Baylor, which integrates arts and humanities into medical education and has received a Association of American Medical Colleges (AAMC) grant supporting its work. His first book, The People's Hospital: Hope and Peril in American Medicine was featured on NPR's Fresh Air with Terry Gross. In its review, The New York Times notes that Ricardo is a “skillful writer who humanizes his points in meticulous and compassionate detail through focusing primarily on the stories of five Ben Taub patients.”

Adjunct Professor in Genetics

Ronjon Nag is an inventor, teacher and entrepreneur. He is an Adjunct Professor in Genetics at the Stanford School of Medicine, becoming a Stanford Distinguished Careers Institute Fellow in 2016. He teaches AI, Genes, Ethics, Longevity Science and Venture Capital. He is a founder and advisor/board member of multiple start-ups and President of the R42 Group, a venture capital firm which invests in, and creates, AI and Longevity companies. As a pioneer of smartphones and app stores, his companies have been sold to Apple, BlackBerry, and Motorola. More recently he has worked on the intersection of AI and Biology. He has been awarded the IET Mountbatten Medal by the Institution of Engineering and Technology, the 2021 IEEE-SCV Outstanding Engineer Award, the 2021 IEEE-USA Leader in Entrepreneurship Spirit Award, and as Chairman of Bounce Imaging winner of the $1m Verizon Powerful Answers Award. Professor Nag has a Ph.D from Cambridge, an M.S from Massachusetts Institute of Technology and a B.Sc. from Birmingham in the UK. He has numerous interests in the intersection of AI and Healthcare including advising companies such as HealX.ai and Oxford Drug Design on computational drug discovery.

Journalist, MacArthur Genius Grant Winner

Sandy started her career covering China and Vietnam as an editor of the Far Eastern Economic Review in the mid-1960s. She became editor of Pacific News Service in 1974 and was a pioneer in developing youth media. In 1996, she founded New America Media, the first and largest collaboration of ethnic news organizations. Her work has received several awards, including a MacArthur Foundation “Genius Award” and the 2011 Polk Award for Career Achievement. In 1996, a film she co-produced, Breathing Lessons, won an Academy Award for best short documentary. She founded Ethnic Media Services in 2017 to continue her work amplifying and elevating the voices of ethnic media.

Educator, Innovator, Investor

Stuart Coulson is an Adjunct Professor at Stanford University’s Institute of Design (the d.school) and a Lecturer at the Graduate School of Business, where he leads Design for Extreme Affordability. In this intensive, project-based program, multi-disciplinary student teams design products and services to tackle poverty in low resource settings. Projects and startups emerging from the program have affected the lives of more than 100 million people so far.

Stuart is an investor in and advisor to early stage technology and social impact organizations in Silicon Valley and his native Ireland. He is a member of Trinity College Dublin’s Provost’s Council, sits on the board of Tangent – Trinity’s Ideas Workspace, and is a founding member of Trinity Angels and the LaunchBox student startup incubator program. He also grows old-vine Zinfandel grapes in California’s Russian River Valley and enjoys regularly quality testing the resulting award-winning wines.

Stuart’s background is in software development, data communications and travel reservations systems. His previous roles include senior leadership in some of the world’s largest travel technology companies and several startups. He co-founded Gradient Solutions, a pioneer in web-based travel e-commerce, acquired by Sabre.

Stuart holds a BA (Mod.) in Computer Science from Trinity College Dublin, an MBA from the University of Geneva and an EMBA from the Tepper Business School, Carnegie Mellon University.